Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ascend Wellness Holdings (AAWH) EBITDA (2020 - 2026)

Ascend Wellness Holdings has reported EBITDA over the past 6 years, most recently at -$17.2 million for Q4 2025.

  • For Q4 2025, EBITDA fell 381.58% year-over-year to -$17.2 million; the TTM value through Dec 2025 reached -$17.0 million, down 459.36%, while the annual FY2025 figure was -$17.0 million, 459.36% down from the prior year.
  • EBITDA for Q4 2025 was -$17.2 million at Ascend Wellness Holdings, down from -$1.3 million in the prior quarter.
  • Over five years, EBITDA peaked at $11.6 million in Q3 2021 and troughed at -$32.0 million in Q1 2021.
  • A 5-year average of -$2.0 million and a median of -$175000.0 in 2022 define the central range for EBITDA.
  • Biggest five-year swings in EBITDA: crashed 1383.08% in 2021 and later surged 981.21% in 2024.
  • Year by year, EBITDA stood at -$731000.0 in 2021, then surged by 836.25% to $5.4 million in 2022, then plummeted by 89.52% to $564000.0 in 2023, then surged by 981.21% to $6.1 million in 2024, then tumbled by 381.58% to -$17.2 million in 2025.
  • Business Quant data shows EBITDA for AAWH at -$17.2 million in Q4 2025, -$1.3 million in Q3 2025, and -$1.0 million in Q2 2025.